Guangmao Yu

448 total citations
34 papers, 264 citations indexed

About

Guangmao Yu is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Guangmao Yu has authored 34 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Guangmao Yu's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Guangmao Yu is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Lung Cancer Treatments and Mutations (7 papers). Guangmao Yu collaborates with scholars based in China. Guangmao Yu's co-authors include Zhifeng Ma, Haiyong Wang, Yuanlin Wu, Chu Zhang, Bin Wang, Zhenhua Zhao, Ting Wang, Ting Zhu, Yong Zeng and Ting Zhu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Guangmao Yu

33 papers receiving 264 citations

Peers

Guangmao Yu
Xiyue Yang China
Hongcheng Liu China
Gladys N. Nangami United States
Guangzheng Deng China
Shuli Tang China
Marco Allasia Italy
Masataka Shimonosono Japan
Elvira Stacher‐Priehse Germany
Yucai Wu China
Qingshan Du China
Xiyue Yang China
Guangmao Yu
Citations per year, relative to Guangmao Yu Guangmao Yu (= 1×) peers Xiyue Yang

Countries citing papers authored by Guangmao Yu

Since Specialization
Citations

This map shows the geographic impact of Guangmao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangmao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangmao Yu more than expected).

Fields of papers citing papers by Guangmao Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangmao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangmao Yu. The network helps show where Guangmao Yu may publish in the future.

Co-authorship network of co-authors of Guangmao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangmao Yu. A scholar is included among the top collaborators of Guangmao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangmao Yu. Guangmao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Guangmao, et al.. (2024). Advancing non-small cell lung cancer treatment: the power of combination immunotherapies. Frontiers in Immunology. 15. 1349502–1349502. 7 indexed citations
2.
Shen, Yujie, et al.. (2024). Sinomenine attenuates pulmonary fibrosis by downregulating TGF-β1/Smad3, PI3K/Akt and NF-κB signaling pathways. BMC Pulmonary Medicine. 24(1). 229–229. 10 indexed citations
3.
Zhu, Ting, Yuanlin Wu, Jiandong Zhang, et al.. (2024). LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis. Journal of Bioenergetics and Biomembranes. 56(2). 181–191. 2 indexed citations
4.
Wang, Bin, et al.. (2023). miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway. Acta Cirúrgica Brasileira. 38. e385223–e385223. 1 indexed citations
5.
Wu, Yuanlin, et al.. (2023). Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55. Biochemical Genetics. 61(4). 1528–1547. 7 indexed citations
6.
7.
Xu, Beihua, et al.. (2022). Preparation and Evaluation of the Cytoprotective Activity of Micelles with DSPE-PEG-C60 as a Carrier Against Doxorubicin-Induced Cytotoxicity. Frontiers in Pharmacology. 13. 952800–952800. 11 indexed citations
8.
Wang, Qihao, et al.. (2022). Tumor-promoting roles of HMMR in lung adenocarcinoma. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 826. 111811–111811. 8 indexed citations
9.
Wu, Yuanlin, Bin Wang, Haiyong Wang, et al.. (2022). Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family‐related genes. Journal of Clinical Laboratory Analysis. 36(6). e24419–e24419. 7 indexed citations
10.
11.
12.
Wang, Haiyong, Bin Wang, Chu Zhang, et al.. (2020). MiR-29c-3p Suppresses the Migration, Invasion and Cell Cycle in Esophageal Carcinoma via CCNA2/p53 Axis. Frontiers in Bioengineering and Biotechnology. 8. 75–75. 25 indexed citations
13.
Wang, Haiyong, Bin Wang, Chu Zhang, et al.. (2020). The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC. PLoS ONE. 15(5). e0233283–e0233283. 21 indexed citations
14.
Zhu, Ting, Zhifeng Ma, Haiyong Wang, et al.. (2020). YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways. Molecular and Cellular Biochemistry. 475(1-2). 137–149. 11 indexed citations
15.
Zhang, Wen, Yiping Zhang, Qiong Zhao, et al.. (2020). Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study. Journal of Thoracic Disease. 12(3). 639–650. 7 indexed citations
16.
Yu, Guangmao, et al.. (2019). <p>MicroRNA-30a-3p inhibits the progression of lung cancer via the PI3K/AKT by targeting DNA methyltransferase 3a</p>. OncoTargets and Therapy. Volume 12. 7015–7024. 30 indexed citations
17.
Zhao, Zhenhua, Ting Wang, Kun Song, et al.. (2018). A Comparison between Prethoracoscopy Localization of Small Pulmonary Nodules by Means of Medical Adhesive versus Hookwire. Journal of Vascular and Interventional Radiology. 29(11). 1547–1552. 10 indexed citations
18.
Su, Dan, et al.. (2017). Study on expression of CDH4 in lung cancer. World Journal of Surgical Oncology. 15(1). 26–26. 12 indexed citations
19.
Wu, Dongping, Xiaoying Chen, Haiyong Wang, et al.. (2017). Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma. Oncology Letters. 13(4). 2745–2750. 12 indexed citations
20.
Feng, Qiang, et al.. (2008). Use of Video-Assisted Thoracoscopy Surgery for the Treatment of Aspergillus Empyema with Bronchopleural Fistula. The Thoracic and Cardiovascular Surgeon. 56(6). 370–372. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiyue Yang Breakdown of academic impact, for papers by Hongcheng Liu Breakdown of academic impact, for papers by Gladys N. Nangami Breakdown of academic impact, for papers by Guangzheng Deng Breakdown of academic impact, for papers by Shuli Tang Breakdown of academic impact, for papers by Marco Allasia Breakdown of academic impact, for papers by Masataka Shimonosono Breakdown of academic impact, for papers by Elvira Stacher‐Priehse Breakdown of academic impact, for papers by Yucai Wu Breakdown of academic impact, for papers by Qingshan Du
Rankless by CCL
2026